1 / 47

Being Ethically Informed When Working With Clients in Need of Medication Assisted Treatment (MAT)

Being Ethically Informed When Working With Clients in Need of Medication Assisted Treatment (MAT). Martina Moore, Ph.D., LPCC-S, LICDC-CS John Carroll University. Overview. Why this Subject? The Perfect Storm Misconceptions about Medication-Assisted Treatment (MAT) What is MAT?

lawrence
Download Presentation

Being Ethically Informed When Working With Clients in Need of Medication Assisted Treatment (MAT)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Being Ethically Informed When Working With Clients in Need of Medication Assisted Treatment (MAT) Martina Moore, Ph.D., LPCC-S, LICDC-CS John Carroll University

  2. Overview • Why this Subject? • The Perfect Storm • Misconceptions about Medication-Assisted Treatment (MAT) • What is MAT? • Ethical Concerns • The Brain on Opioids • Forms of MAT • Best Practice for Treating OUD

  3. Why this Subject?

  4. The Perfect Storm

  5. Counselors Misconceptions About MAT • The counselor does not know what is MAT. • The counselor does not understand the evidence based research in support of MAT. • The counselor has heard and believe many of the myths about MAT. • The counselor believes that all forms of MAT can be diverted.

  6. What Is Medication Assisted Treatment For Opioid Addiction? Medication-Assisted Treatment (MAT) for opioid addiction is the use of medications, such as buprenorphine, naltrexone and methadone (in combination with counseling and behavioral therapies) to provide a whole-patient approach to treatment. MAT works to… • Stabilize brain chemistry • Block the euphoric effects of opioids • Relieve physiological cravings • Normalize body functions National Council for Behavioral Health

  7. What Is Medication Assisted Treatment For Opioid Addiction? • Studies have shown that MAT reduces illicit drug use, disease rates and related harmful behaviors, including criminal activity. People in MAT are up to 75% less likely to die from a cause related to their addiction. Despite what the National Institute of Health says is “unequivocal” evidence of MAT’s effectiveness and safety, many myths persist about MAT. As a result, people are denied potentially life saving addiction treatment. National Council for Behavioral Health

  8. Benefits of MAT

  9. Underutilization of MAT • Medication-assisted treatments remain grossly underutilized: • Mostly where stigma and negative attitudes persist among clinic staff and administrators.   • This leads to insufficient dosing or limitations on the duration of use of these medications. • Which often leads to treatment failure.

  10. Common Counselor Ethical Dilemmas • A.4.b. Personal Values • C.2. Professional Competence • C.7.a. Scientific Basis for Treatment When providing services, counselors use techniques/procedures/modalities that are grounded in theory and/or have an empirical or scientific foundation.

  11. Personal Story

  12. The Brain and Opiates

  13. The Body’s Natural Opioid System • The body naturally releases several different opioids during behaviors like exercising, eating and socializing. • When these opioids attach to receptors they can: • Suppress pain • Slow breathing • Produce a sense of calm Opioid Misuse and Addiction: Strategies for Community Health Workers

  14. Opioids • In addition to the body’s natural opioids, there are substances that act on the same opioid receptors in the brain. • They produce a much stronger effect than natural opioids. • These substances have medical uses, and are one of the most commonly prescribed medications for short-term and chronic pain.

  15. Common Opioids • Prescription Pain Relievers • Hydrocodone • Oxycodone • Percocet • Vicodin • Morphine • Codeine • Fentanyl* • Illicit Opioids • Heroin • Maintenance Medications • Methadone

  16. Opioid Addiction • Opioid use is habit-forming, especially when opioids are not taken as prescribed. • Opioid addiction can be described using three basic components: • Overwhelming psychological desire to use opioids • Increased tolerance to opioids • Withdrawal symptoms when opioids are unavailable Opioid Misuse and Addiction: Strategies for Community Health Workers

  17. Opioid Seeking Behavior • Opioids disrupt the natural reward system by flooding the brain with large amounts of dopamine. • People addicted to opioids experience uncontrollable cravings for opioids that persist after they stop taking the drug. Opioid Misuse and Addiction: Strategies for Community Health Workers

  18. Opioid Tolerance • After a period of use, opioid receptors become less sensitive to opioids • This means that an individual requires a larger dose to achieve the same effect

  19. Withdrawal • As the body gets used to a regular dose of opioids, it slows production of natural opioids • When the dose is not taken, the body experiences uncomfortable withdrawal symptoms Opioid Misuse and Addiction: Strategies for Community Health Workers

  20. Addiction

  21. 7 MYTHS About MAT

  22. MYTHS About MAT MYTH #1: MAT Trades One Addiction For Another • FACT: MAT bridges the biological and behavioral components of addiction. Research indicates that a combination of medication and behavioral therapies can successfully treat SUDs and help sustain recovery. National Council for Behavioral Health

  23. MYTHS About MAT MYTH #2: MAT Is Only For The Short Term • FACT: Research shows that patients on MAT for at least 1-2 years have the greatest rates of long-term success. There is currently no evidence to support benefits from cessation. • FACT: Patients with long-term abstinence can follow a slow taper schedule under a physician’s direction, when free of stressors, to attempt dose reduction or total cessation. National Council for Behavioral Health

  24. MYTHS About MAT MYTH #3: Many Patients’ Addiction Conditions Are Not Severe Enough to Require MAT • FACT: MAT utilizes a multitude of different medication options (agonists, partial agonists and antagonists) that can be tailored to fit the unique needs of the patient. National Council for Behavioral Health

  25. MYTHS About MAT MYTH #4: MAT Increases The Risk For Overdose In Patients • FACT: MAT helps to prevent overdoses from occurring. Even a single use of opioids after detoxification can result in a life-threatening or fatal overdose. Following detoxification, tolerance to the euphoria brought on by opioid use remains higher than tolerance to respiratory depression. National Council for Behavioral Health

  26. MYTHS About MAT MYTH #5: Providing MAT Will Only Disrupt and Hinder a Patient’s Recovery Process • FACT: MAT has been shown to assist patients in recovery by improving quality of life, level of functioning and the ability to handle stress. Above all, MAT helps reduce mortality while patients begin recovery. National Council for Behavioral Health

  27. MYTHS About MAT MYTH #6: There Isn’t Any Proof That MAT Is Better Than Abstinence • FACT: MAT is evidence-based and is the recommended course of treatment for opioid addiction. The National Institute on Drug Abuse, Substance Abuse and Mental Health Services Administration, National Institute on Alcohol Abuse and Alcoholism, Centers for Disease Control and Prevention, and other agencies emphasize MAT as first line treatment. National Council for Behavioral Health

  28. MYTHS About MAT MYTH #7: Most Insurance Plans Don’t Cover MAT • FACT: As of May 2013, 31 state Medicaid FFS programs covered methadone maintenance treatment provided in outpatient programs. State Medicaid agencies vary as to whether buprenorphine is listed on the Preferred Drug List (PDL), and whether prior authorization is required (a distinction often made based on the specific buprenorphine medication type). Extended-release naltrexone is listed on the Medicaid PDL in over 60 percent of states. National Council for Behavioral Health

  29. Forms of MAT

  30. 3 MAT Options

  31. History of Naltrexone/Vivitrol • Naltrexone has been around for decades as a treatment for those struggling with alcohol use disorders, first in pill form and now as a once-a-month injection marketed under the name Vivitrol. • In the 1980s naltrexone was only available in the pill form. It became evident that many found it hard to commit to taking pills consistently, especially when they know that by skipping doses, they will be able to feel high from opioids or alcohol within a couple days. • The arrival of the extended-release form of naltrexone, Vivitrol, approved in 2006 for alcohol dependence and in 2010 for opioid dependence, eliminated these concerns for those who feared they may have trouble with compliance.

  32. Naltrexone/Vivitrol for Opioid Use Disorders and Alcohol

  33. Challenges with Naltrexone/Vivitrol • Mandatory withdrawal period (recommended 10 days) • Not having injection prior to leaving jail • Relapse on another drug (i.e. cocaine) • Not engaged immediately into treatment • Opting out of ongoing injections • Attempts to overcome opioid blockade due to Vivitrol may result in fatal overdose • Cost

  34. Methadone In the 1960s Methadone was found to be an effective and important drug for treating pain as well as drug treatment for heroin addiction. Methadone has sedative effects, and if taken in high doses can create euphoria that can lead to addiction.

  35. Methadone • Methadone is the most highly regulated and controlled area in addiction treatment, and also one of the most highly regulated in all medicine. In the eyes of the public, policy makers, as well as health and social service providers, there is an unfortunate stigma associated with methadone and people who receive Methadone Maintenance Treatment (MMT).  • A limitation of methadone is availability. • You can only obtain it in an OTP setting, which are infrequently found in rural and Appalachian areas.

  36. MethadoneFull Agonist • Activates opioid receptors • Abuse is possible • Clients may alternate between opioids and methadone or sell their excess take home supply • Methadone treatment follows structural procedures such as required frequent visits • Methadone treatment should be considered a longer term treatment because there is a high probability in relapse to opioids if ending treatment in less than a year

  37. Methadone

  38. Methadone

  39. Buprenorphine/Suboxone/Subutex Buprenorphine/suboxone began as a pain reliever for treating severe, chronic pain. In very small doses it proved to be more effective than morphine. While the drug activates some of the same receptors as heroin and morphine, reasons for success include: the drug’s ceiling effect and low side effect profile compared to other drugs. The drug has a slight chance to give the patient an euphoric feeling, but only if the patient is opiate-naïve and only for a very limited time.

  40. Buprenorphine/Suboxone/Subutex

  41. Buprenorphine/Suboxone/SubutexPartial Agonist • Activates opioid receptors but produces a diminished response • Taking central nervous system depressants such as alcohol, sedatives and tranquilizers is really dangerous • Can be more addictive than the opiates that the patients are trying to get free from • Although it does not have similar narcotic effects that some opiates have, it does have a lightly nostalgic and calming opiate euphoric effect • The use of suboxone has been one of the most controversial issues in the medical history until today • Diversion of suboxone • Doctor weekly, bi-weekly, or monthly visits

  42. Evidence Based Best Practice for Treating OUD

  43. Evidence Based Best Practice for Treating OUD • Medication Assisted Treatment • Long term substance use disorder treatment (at least 18 months) • Non-traditional case management • Psychiatrist • Family involvement • Peer recovery coaching • Outpatient and intensive counseling • Residential placement • Vocational rehabilitation services • Spiritual Care • Probation

  44. Opioid Treatment ProgramsEvidence- Based Programs

  45. Case • Peggy is a 24-year-old white female who has been using heroin for three years. She reports spending about $50 to $100 per day on heroin. She comes from an upper middle-class family in the Cleveland area. She first began abusing opiates after a sports injury four years ago. She has never had treatment for addiction, and this is her first assessment for placement in a level of care. You are completing her assessment in jail due to her being arrested 12 days ago for solicitation.

  46. The End

  47. Contact Information

More Related